Hostname: page-component-7b7567c8c-p67k6 Total loading time: 0 Render date: 2026-11-19T09:59:04.617Z Has data issue: false hasContentIssue false

Intended bilateral cardiac sympathetic denervation in children and young adults with severe adrenergically mediated ventricular arrhythmias: a single-centre experience

Published online by Cambridge University Press:  19 November 2026

Serkan Uysal
Affiliation:
Department of Thoracic Surgery, Hacettepe University, Faculty of Medicine , Türkiye
Ayşe Ali Hasan*
Affiliation:
Department of Thoracic Surgery, Hacettepe University, Faculty of Medicine , Türkiye
İlker Ertuğrul
Affiliation:
Department of Pediatric Cardiology, Hacettepe University, Faculty of Medicine, Türkiye
Tevfik Karagöz
Affiliation:
Department of Pediatric Cardiology, Hacettepe University, Faculty of Medicine, Türkiye
Mustafa Yılmaz
Affiliation:
Department of Cardiovascular Surgery, Hacettepe University, Faculty of Medicine, Türkiye
*
Corresponding author: Ayşe Ali Hasan; Email: ayse.hasan12@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Objective:

Left cardiac sympathetic denervation is established for selected high-risk inherited arrhythmia syndromes, but evidence for an intended bilateral strategy in children and young adults remains limited. We evaluated the rationale, feasibility, safety, follow-up ascertainment, and outcomes of intended bilateral cardiac sympathetic denervation.

Methods:

Consecutive children and young adults undergoing intended bilateral cardiac sympathetic denervation between January 2015 and November 2025 were reviewed. The operation targeted the lower stellate component and upper thoracic sympathetic chain bilaterally, usually through single-port thoracoscopic access. Outcomes were obtained from specialist cardiology follow-up, electrocardiography, Holter monitoring, exercise testing when available, inpatient telemetry, device interrogation, and medication records.

Results:

Thirty-seven patients were operated. Mean age was 12.4 years. Bilateral denervation was completed in 36 patients; 1 underwent left-sided denervation only owing to intraoperative haemodynamic instability. Single-port access was used in 30 patients. There were no intraoperative deaths, unplanned full thoracotomy conversions, intercostal injuries, reoperations for surgical complications, or denervation-related permanent pacing. Procedure-attributable morbidity comprised one mild Horner syndrome and one self-limited axillary wound complaint. Among 36 patients with post-discharge follow-up, 32 remained free from the primary malignant ventricular arrhythmic endpoint. Estimated malignant ventricular arrhythmia-free survival was 95.8 per cent at 1 year and 89.4 per cent at 3 years.

Conclusion:

Intended bilateral cardiac sympathetic denervation was feasible and had low procedure-attributable morbidity in selected young patients. It should be interpreted as an adjunct to multidisciplinary arrhythmia care, not as a replacement for medication, device surveillance, or follow-up.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press
Figure 0

Figure 1.Figure 1 long description.Flow diagram of the operated cohort and outcome analysis population. The diagram shows 37 operated patients who underwent intended bilateral cardiac sympathetic denervation, the 36 patients with evaluable post-discharge follow-up, the 1 patient excluded from durable outcome analysis because post-operative follow-up was very early at data lock, and the primary time-to-event, descriptive follow-up, and device-status analysis pathways.

Figure 1

Table 1.Baseline and operative characteristics of the cohortTable 1 long description.

Figure 2

Figure 2.Figure 2 long description.Kaplan–Meier estimate of malignant ventricular arrhythmia-free survival after intended bilateral cardiac sympathetic denervation. Events were defined as sustained ventricular tachycardia or ventricular fibrillation requiring intervention, appropriate implantable cardioverter-defibrillator therapy, arrhythmic syncope, cardiac arrest, or arrhythmic death. Patients without the primary endpoint were censored at last available clinical or device follow-up. Four primary endpoint events occurred, and 32 patients were censored. Estimated malignant ventricular arrhythmia-free survival was 95.8 per cent at 1 year and 89.4 per cent at 3 years. Mean malignant ventricular arrhythmia-free survival was 7.0 years, with a 95 per cent confidence interval of 5.8 to 8.2 years. Median malignant ventricular arrhythmia-free survival was not reached. Later estimates should be interpreted cautiously because few patients remained at risk. Number at risk at 0, 1, 2, 3, 4, 5, 6, 7, and 8 years: 36, 18, 16, 14, 9, 6, 3, 3, and 1, respectively.

Figure 3

Table 2.Follow-up ascertainment and clinical outcomes after intended bilateral cardiac sympathetic denervationTable 2 long description.

Supplementary material: File

Uysal et al. supplementary material

Uysal et al. supplementary material
Download Uysal et al. supplementary material(File)
File 150.6 KB